ANNEXON, INC. Shares Authorized
ANNEXON, INC. (ANNX) had Shares Authorized of 300.00 million shares as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-03-30
- 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2024-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2023-12-31: Common Stock, Shares Authorized 300.00M shares.
- 2022-12-31: Common Stock, Shares Authorized 300.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2025-12-31 | 300.00M shares 10-K · filed 2026-03-30 |
| 2024-12-31 | 300.00M shares 10-K · filed 2026-03-30 |
| 2023-12-31 | 300.00M shares 10-K · filed 2025-03-03 |
| 2022-12-31 | 300.00M shares 10-K · filed 2024-03-26 |
| 2021-12-31 | 300.00M shares 10-K · filed 2023-03-06 |
| 2020-12-31 | 300.00M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 300.00M shares 10-Q · filed 2020-11-16 |
| 2020-06-30 | 239.10M shares 10-Q · filed 2020-09-08 |
| 2019-12-31 | 150.00M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |